Free Trial
→ Think NVDA’s run was epic? You ain’t seen nothin’ yet (From Timothy Sykes) (Ad) Buy NLSP Stock  Free NLSP Stock Alerts

NLS Pharmaceutics (NLSP) SEC Filings & 10K Form

NLS Pharmaceutics logo
$1.92 -0.04 (-1.79%)
As of 01:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/01/2025
8:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
12/03/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
8:16 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
07/01/2024
7:26 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 424B5
07/01/2024
7:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
3:54 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
06/25/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
8:28 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
8:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
4:25 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSP) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored